Compile Data Set for Download or QSAR
Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 13300
TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775078(US20250304587, Compound 5)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775077(US20250304587, Compound 4b)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775076(US20250304587, Compound 4a)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775075(US20250304587, Compound 4)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775081(US20250304587, Compound 7)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775080(US20250304587, Compound 6a)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775079(US20250304587, Compound 6)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775086(US20250304587, Compound 30)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775085(US20250304587, Compound 28)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775084(US20250304587, Compound 23a)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775083(US20250304587, Compound 17)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775093(US20250304587, Compound 51a)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775092(US20250304587, Compound 44a)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775091(US20250304587, Compound 41b)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775074(US20250304587, Compound 3)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775090(US20250304587, Compound 39b)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775089(US20250304587, Compound 37b)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775088(US20250304587, Compound 37a)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775087(US20250304587, Compound 32)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775094(US20250304587, Compound 58b)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775082(US20250304587, Compound 7a)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775097(US20250304587, Compound 38b)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775096(US20250304587, Compound 65a)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775095(US20250304587, Compound 61b)
Affinity DataIC50: 7.5nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775057(US20250304587, Compound 2)
Affinity DataIC50: 55nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775056(US20250304587, Compound 1)
Affinity DataIC50: 55nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM50638470(Azenosertib | Zn-c3 | ZN-C3 | US20250304587, Compo...)
Affinity DataIC50: 55nMAssay Description:WEE1 (Thermo Fisher, Cat #PR7373A) protein in buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) at 15 nM) in different concentration...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetCytochrome P450 2C19(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775082(US20250304587, Compound 7a)
Affinity DataIC50: 5.50E+3nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2C19(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775098(US20250304587, Compound 44)
Affinity DataIC50: 5.50E+3nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2C19(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 5.50E+3nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775074(US20250304587, Compound 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775074(US20250304587, Compound 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2B6(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2C8(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2C8(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775074(US20250304587, Compound 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2D6(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775074(US20250304587, Compound 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2C19(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775074(US20250304587, Compound 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2C9(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775074(US20250304587, Compound 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2C9(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775082(US20250304587, Compound 7a)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775082(US20250304587, Compound 7a)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775082(US20250304587, Compound 7a)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775089(US20250304587, Compound 37b)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775089(US20250304587, Compound 37b)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2C8(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775082(US20250304587, Compound 7a)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2D6(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM775082(US20250304587, Compound 7a)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2D6(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 2C9(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Jiangsu Tasly Diyi Pharmaceutical Co.

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 1.00E+4nMAssay Description:Enzymatic experiments were performed to quantify the inhibition of CYP450 enzyme activity of each isoform of CYP450 by small molecule inhibitors thro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: